WallStreetZenWallStreetZen

NASDAQ: MEDP
Medpace Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Medpace Holdings earnings were $365.7M for the trailing 12 months ending Sep 30, 2024, with 34% growth year over year. The latest MEDP earnings report on Sep 30, 2024 announced Q3 2024 earnings of $96.4M, up 9.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, MEDP reported annual earnings of $282.8M, with 15.3% growth. The next MEDP earnings date is Feb 10, 2025.

MEDP past earnings growth

How has MEDP's earnings growth performed historically?

Company
33.98%
Industry
-6.84%
Market
48.94%
MEDP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
MEDP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
MEDP's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

MEDP earnings history

Current Revenue
$2.1B
Current Earnings
$365.7M
Current Profit Margin
17.7%

MEDP Return on Equity

Current Company
50.9%
Current Industry
-13.8%
Current Market
35%
MEDP's Return on Equity (50.9%)... subscribe to Premium to read more.
High Return on Equity Performance

MEDP Return on Assets

Current Company
19.6%
Current Industry
5.9%
MEDP is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MEDP announces earnings.

MEDP Return on Capital Employed

Current Company
39.68%
Current Industry
10.5%
MEDP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MEDP vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MEDP$464.88M$365.67M+35.29%$11.83
QGEN$368.60M$92.93M-19.32%$0.37
EXAS$58.24M-$214.04MN/A-$1.17
CRL$986.15M$413.08M+10.99%$8.05
RVTY$729.58M$254.30M-0.29%$2.08
View Top Diagnostic & Research Stocks

MEDP earnings dates

Next earnings date
Feb 10, 2025

Medpace Holdings Earnings Reports & History FAQ

What were Medpace Holdings's earnings last quarter?

On MEDP's earnings call on Invalid Date, Medpace Holdings (NASDAQ: MEDP) reported Q3 2024 earnings per share (EPS) of $3.11, up 35.22% year over year. Total MEDP earnings for the quarter were $96.43 million. In the same quarter last year, Medpace Holdings's earnings per share (EPS) was $2.30.

If you're new to stock investing, here's how to buy Medpace Holdings stock.

When does Medpace Holdings report earnings?

The next MEDP earnings call is Invalid Date. Add MEDP to your watchlist to be reminded of Medpace Holdings's next earnings date.

What was MEDP's earnings growth in the past year?

As of Medpace Holdings's earnings date in Invalid Date, Medpace Holdings's earnings has grown 33.98% year over year. This is 40.82 percentage points higher than the US Diagnostics & Research industry earnings growth rate of -6.84%. MEDP earnings in the past year totalled $365.67 million.

Is Medpace Holdings profitable or losing money?

As of the last Medpace Holdings earnings report, Medpace Holdings is currently profitable. Medpace Holdings's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $365.67 million, a 33.85% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.